column
2022, 26(1): 18-21.
DOI: 10.7619/jcmp.20213494
2022, 26(1): 36-38,43.
DOI: 10.7619/jcmp.20213502
2022, 26(1): 71-75, 94.
DOI: 10.7619/jcmp.20213887
2022, 26(1): 95-98.
DOI: 10.7619/jcmp.20212098
2022, 26(1): 109-115.
DOI: 10.7619/jcmp.20212670
Research progress on influence of clinical drugs on antitumor effect of immune checkpoint inhibitors
2022, 26(1): 120-122, 133.
DOI: 10.7619/jcmp.20212975
2022, 26(1): 123-128.
DOI: 10.7619/jcmp.20213259
2022, 26(1): 129-133.
DOI: 10.7619/jcmp.20213870
2022, 26(1): 134-138, 148.
DOI: 10.7619/jcmp.20213661
2022, 26(1): 139-142.
DOI: 10.7619/jcmp.20212567